Homburger advised Elanco in Switzerland on any aspect of Swiss law within the transaction. The background On the 13th of August 2024, Elanco Animal Health and Elanco US entered into an incremental assumption agreement to obtain an incremental term facility. The granting of the comprehensive security package involving various jurisdictions was completed on September 9, […]
Homburger acted as counsel to SMBC Group in its capacity as documentation agent in connection with an English law-governed JPY 42,000 million (around CHF 250 million) sustainability-linked Samurai loan with Axpo Holding as borrower and an international
Homburger, on October 24, 2024, advised Avolta on a refinancing deal of its revolving credit facility (RCF). The amended EUR 2,400 m RCF with maturity in 2029 replaces the EUR 2,750 m RCF expiring in 2027. Avolta Avolta is a Swiss-based
Kellerhals Carrard advised Panakes Partners in leading the EUR 17.9 million Series B financing round of Lymphatica Medtech. This round was co-led by TechWald Holding S.p.A., and CDP Venture Capital SGR, with participation from
Niederer Kraft Frey (NKF) advised CREAL SA on its successful Series B Prime financing round, which was led by Carl Zeiss Vision International GmbH. NKF also advised CREAL on a strategic license agreement with ZEISS,
Homburger has advised Hevolution Foundation on its participation in a Series A investment round in Vandria, which raised a total of USD 30.7 million. Hevolution Foundation, a global non-profit organisation dedicated to advancing health span science
Walder Wyss has advised 14Trees on the completion of an exclusive Series A-1 round backed by Amazon’s Climate Pledge Fund, alongside founding investor Holcim. The joint investment enables the rollout of 3D printing in
Niederer Kraft Frey (NKF) acted as Swiss legal advisor to Varta in connection with a German law bridge financing agreement, securing essential liquidity for the company as it continues its restructuring under the German StaRUG
Orrick and Kellerhals Carrard assisted Partech, as lead investor through the Impact Growth Fund, in the €36 million Series C round of xFarm Technologies,focusing on the digitalization of the agri-food sector. Kellerhals Carrard team For
Baker McKenzie acted for UBS Switzerland (“UBS”) as sole underwriter, mandated lead arranger, bookrunner, agent and security agent; and a group of Swiss and foreign lenders in connection with the amendment of ATP adhesive systems’
